ArticleDigestive diseases and sciences2023

Vedolizumab and Adalimumab in Biologic-Naïve Ulcerative Colitis: Comparison of Patient-Level Clinical Trial Data and VARSITY for Week 6 Clinical Remission.

Neeraj Narula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.